Stoke Therapeutics Inc. United States of America (USA)

Research

Date range: 1 March 2021 - 28 February 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Stoke Therapeutics Inc. published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Stoke Therapeutics Inc.
Count Share
1 0.18

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.18

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 1.58

Compare Stoke Therapeutics Inc. with other institutions

Collaboration

Date range: 1 March 2021 - 28 February 2022

International vs. domestic collaboration by Share

  • 100.00% Domestic
  • 0.00% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Stoke Therapeutics Inc. by Share (5 total)

  1. Stoke Therapeutics Inc. and Ionis Pharmaceuticals, Inc. (0.45)
    Stoke Therapeutics Inc.0.18
    Ionis Pharmaceuticals, Inc.0.27
  2. Stoke Therapeutics Inc. and Cold Spring Harbor Laboratory (CSHL) (0.45)
    Stoke Therapeutics Inc.0.18
    Cold Spring Harbor Laboratory (CSHL)0.27
  3. Stoke Therapeutics Inc. and University of Michigan (U-M) (0.27)
    Stoke Therapeutics Inc.0.18
    University of Michigan (U-M)0.09
  4. Stoke Therapeutics Inc. and Mount Sinai Health System (MSHS) (0.27)
    Stoke Therapeutics Inc.0.18
    Mount Sinai Health System (MSHS)0.09
  5. Stoke Therapeutics Inc. and State University of New York at Stony Brook (SUNY Stony Brook) (0.27)
    Stoke Therapeutics Inc.0.18
    State University of New York at Stony Brook (SUNY Stony Brook)0.09

Top 10 international collaborators with Stoke Therapeutics Inc. by Share (0 total)